Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 565080, 6 pages
http://dx.doi.org/10.1155/2014/565080
Clinical Study

Serum C-Reactive Protein and Procalcitonin Kinetics in Patients Undergoing Elective Total Hip Arthroplasty

1Department of Surgery, University Hospital of Siena, Viale Bracci No. 16, 53100 Siena, Italy
2Orthopaedics and Traumatology Clinic, University Hospital of Siena, Viale Bracci No. 16, 53100 Siena, Italy
3Department of Internal Medicine, University Hospital of Siena, Viale Bracci No. 16, 53100 Siena, Italy

Received 5 February 2014; Revised 7 April 2014; Accepted 16 April 2014; Published 4 May 2014

Academic Editor: Akihiro Sudo

Copyright © 2014 Sandra Battistelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Pulido, E. Ghanem, A. Joshi, J. J. Purtill, and J. Parvizi, “Periprosthetic joint infection: the incidence, timing, and predisposing factors,” Clinical Orthopaedics and Related Research, vol. 466, no. 7, pp. 1710–1715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. F. M. Choong, M. M. Dowsey, D. Carr, J. Daffy, and P. Stanley, “Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen,” Acta Orthopaedica, vol. 78, no. 6, pp. 755–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Phillips, T. P. Crane, M. Noy, T. S. J. Elliott, and R. J. Grimer, “The incidence of deep prosthetic infections in a specialist orthopaedic hospital. A 15-year prospective survey,” Journal of Bone and Joint Surgery B, vol. 88, no. 7, pp. 943–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Ridker, “High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease,” Circulation, vol. 103, no. 13, pp. 1813–1818, 2001. View at Google Scholar · View at Scopus
  5. S. Tsimikas, J. T. Willerson, and P. M. Ridker, “C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. C19–C31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Rothenburger, A. Markewitz, T. Lenz et al., “Detection of acute phase response and infection. The role of procalcitonin and C-Reactive protein,” Clinical Chemistry and Laboratory Medicine, vol. 37, no. 3, pp. 275–279, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Jullienne, N. Segond, and C. Calmettes, “Biosynthesis of human calcitonin: evidence for a prohormone,” Biochemical and Biophysical Research Communications, vol. 95, no. 3, pp. 932–937, 1980. View at Google Scholar · View at Scopus
  8. M. Zaidi, A. S. Alam, V. S. Shankar et al., “A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function,” European Biophysics Journal, vol. 21, no. 5, pp. 349–355, 1992. View at Google Scholar · View at Scopus
  9. R. H. Snider Jr., E. S. Nylen, and K. L. Becker, “Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization,” Journal of Investigative Medicine, vol. 45, no. 9, pp. 552–560, 1997. View at Google Scholar · View at Scopus
  10. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon, “High serum procalcitonin concentrations in patients with sepsis and infection,” The Lancet, vol. 341, no. 8844, pp. 515–518, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Carsin, M. Assicot, F. Feger et al., “Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFα and endotoxin levels early after thermal injury,” Burns, vol. 23, no. 3, pp. 218–224, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Wanner, M. Keel, U. Steckholzer, W. Beier, R. Stocker, and W. Ertel, “Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients,” Critical Care Medicine, vol. 28, no. 4, pp. 950–957, 2000. View at Google Scholar · View at Scopus
  13. M. Meisner, K. Tschaikowsky, A. Hutzler, C. Schick, and J. Schüttler, “Postoperative plasma concentrations of procalcitonin after different types of surgery,” Intensive Care Medicine, vol. 24, no. 7, pp. 680–684, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. J. G. DeLee and J. Charnley, “Radiological demarcation of cemented sockets in total hip replacement,” Clinical Orthopaedics and Related Research, vol. 121, pp. 20–32, 1976. View at Google Scholar · View at Scopus
  15. T. A. Gruen, G. M. McNeice, and H. C. Amstutz, ““Modes of failure” of cemented stem-type femoral components. A radiographic analysis of loosening,” Clinical Orthopaedics and Related Research, vol. 141, pp. 17–27, 1979. View at Google Scholar · View at Scopus
  16. C. A. Engh, A. H. Glassman, and K. E. Suthers, “The case for porous-coated hip implants: the femoral side,” Clinical Orthopaedics and Related Research, no. 261, pp. 63–81, 1990. View at Google Scholar · View at Scopus
  17. C. Dupont, J. Rodenbach, and E. Flachaire, “The value of C-reactive protein for postoperative monitoring of lower limb arthroplasty,” Annales de Readaptation et de Medecine Physique, vol. 51, no. 5, pp. 348–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. O. Niskanen, O. Korkala, and H. Pammo, “Serum C-reactive protein levels after total hip and knee arthroplasty,” Journal of Bone and Joint Surgery B, vol. 78, no. 3, pp. 431–433, 1996. View at Google Scholar · View at Scopus
  19. M. Sedlář, Z. Kudrnová, S. Trča et al., “Inflammatory response in patients undergoing hip surgery due to osteoarthrosis or different types of hip fractures,” Osteoarthritis and Cartilage, vol. 16, no. 1, pp. 26–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Ghanem, V. Antoci Jr., L. Pulido, A. Joshi, W. Hozack, and J. Parvizi, “The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty,” International Journal of Infectious Diseases, vol. 13, no. 6, pp. e444–e449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. del Pozo and R. Patel, “Infection associated with prosthetic joints,” New England Journal of Medicine, vol. 361, no. 8, pp. 787–794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. L. Becker, R. Snider, and E. S. Nylen, “Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target,” British Journal of Pharmacology, vol. 159, no. 2, pp. 253–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Chirouze, H. Schuhmacher, C. Rabaud et al., “Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever,” Clinical Infectious Diseases, vol. 35, no. 2, pp. 156–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Bottner, A. Wegner, W. Winkelmann, K. Becker, M. Erren, and C. Götze, “Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement,” Journal of Bone and Joint Surgery B, vol. 89, no. 1, pp. 94–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Meisner, C. Rauschmayer, J. Schmidt et al., “Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications,” Intensive Care Medicine, vol. 28, no. 8, pp. 1094–1102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. C. J. Chevillotte, M. H. Ali, R. T. Trousdale, D. R. Larson, R. E. Gullerud, and D. J. Berry, “Inflammatory laboratory markers in periprosthetic hip fractures,” Journal of Arthroplasty, vol. 24, no. 5, pp. 722–727, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Fottner, C. Birkenmaier, C. von Schulze Pellengahr, B. Wegener, and V. Jansson, “Can Serum Procalcitonin Help to Differentiate Between Septic and Nonseptic Arthritis?” Arthroscopy, vol. 24, no. 2, pp. 229–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Hunziker, T. Hügle, K. Schuchardt et al., “The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery,” Journal of Bone and Joint Surgery A, vol. 92, no. 1, pp. 138–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Sponholz, Y. Sakr, K. Reinhart, and F. Brunkhorst, “Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature,” Critical Care, vol. 10, no. 5, article R145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Uçkay, C. Garzoni, T. Ferry et al., “Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections,” Swiss Medical Weekly, vol. 140, Article ID w13124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Boussekey, O. Leroy, H. Georges, P. Devos, T. D'Escrivan, and B. Guery, “Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit,” Infection, vol. 33, no. 4, pp. 257–263, 2005. View at Publisher · View at Google Scholar · View at Scopus